Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry is delighted to share its bioanalytical testing laboratory in Cambridge, MA through a facility tour at BPI. This is an extension of their contract testing capabilities currently on offer in Scotland. The custom built, state-of-the-art laboratories were opened in November 2016 and offers contract testing services to biopharmaceutical companies. The bioanalytical assay portfolio predominantly focused on mAbs includes target binding by SPR and ELISA, potency assays (development, qualification & validation for Lot Release & Stability), ADCC, CDC and full service SPR. The experienced team of scientists also support GMP biosafety testing on a range of products including Gene Therapies. Please join us for an afternoon of refreshments along with a facility overview and tour. To find out more about our contract testing services, visit www.biooutsource.com.